Memorandum of Understanding Signing Ceremony between Bioprocessing Technology Institute, A*STAR, Institute of Molecular and Cell Biology, A*STAR, and SCG Cell Therapy
10 May 2023
We are excited to announce the signing of a Memorandum of Understanding between Bioprocessing Technology Institute, Institute of Molecular and Cell Biology and SCG Cell Therapy, setting the stage for a remarkable collaboration in cell and gene therapy (CGT). A*STAR has deep capabilities in bioprocessing technologies, manufacturing, biomarker discovery and target validation, while SCG is a leading biotechnology company with expertise in clinical development of novel immunotherapies.
Together, this meaningful partnership aims to:
- Advance CGT manufacturing process development and analytics.
- Accelerate the development and delivery of novel immunotherapies into clinics.
We look forward to working with SCG to develop cell and gene therapies to contribute towards better healthcare outcomes.